... oncosphere antigens 六钩蚴抗原类 oral anticoagulants 口服抗凝剂 oral apparatuses 口腔装置 ...
基于22个网页-相关网页
novel oral anticoagulants-NOACs 新型的口服抗凝药物
Oral anticoagulants take effect by inhibiting the pathway of coagulation.
抗凝药物通过对凝血途径加以抑制而起效。
For patients who are receiving a stable dose of oral anticoagulants, we suggest monitoring at an interval of no longer than every 4 weeks (Grade 2c).
对于使用稳定剂量口服抗凝剂的患者,我们推荐凝血功能监测时间间隔不超过4周(2 C)。
This study exemplifies that novel, specific oral anticoagulants may improve the current antithrombotic strategies while having a safer bleeding profile.
这项研究例证了新型特异性口服抗凝药可改善当前的抗血栓治疗方法,并有有着较为安全的出血特性。
应用推荐